Distribution of dopamine D 2-like receptors in the rat amygdala and their role in the modulation of unconditioned fear and anxiety

Neuroscience

Volumn 201, Issue , 2012, Pages 252-266

  De la Mora, M Perez ^a   Gallegos Cari, A ^a   Crespo Ramirez, M ^a   Marcellino, D ^b   Hansson, A C ^c   Fuxe, K ^b  

^a INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

^b KAROLINSKA INSTITUTE   (Sweden)

^c CENTRAL INSTITUTE OF MENTAL HEALTH   (Germany)

Author keywords

CeA (amygdaloid central nucleus); Intercalated paracapsular islands; Raclopride; Shock probe burying test; Stress

Indexed keywords

DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; RACLOPRIDE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANXIETY; ARTICLE; AUTORADIOGRAPHY; BASOLATERAL AMYGDALA; CENTRAL NUCLEUS (AMYGDALA); CONTROLLED STUDY; EXPERIMENTAL TEST; FEAR; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MAZE TEST; NEUROMODULATION; NONHUMAN; OPEN FIELD TEST; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; RECEPTOR DENSITY; SHOCK PROBE BURYING TEST;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ANXIETY; AUTORADIOGRAPHY; CONDITIONING (PSYCHOLOGY); DOPAMINE ANTAGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROSHOCK; EXPLORATORY BEHAVIOR; FEAR; GENE EXPRESSION REGULATION; MALE; MAZE LEARNING; RACLOPRIDE; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RNA, MESSENGER;

EID: 84855524167     PISSN: 03064522     EISSN: 18737544     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.10.045     Document Type: Article

References (85)

1. Abercrombie E.D., Keefe K.A., DiFrischia D.S., Zigmond M.J. Differential effect of stress on in vivo dopamine release in striatum, nucleus accumbens, and medial frontal cortex. J Neurochem 1989, 52:1655-1658.
2. Arnsten A.F. Catecholamine regulation of the prefrontal cortex. J Psychopharmacol 1997, 11:151-162.
3. Asan E. Comparative single and double immunolabelling with antisera against catecholamine biosynthetic enzymes: criteria for the identification of dopaminergic, noradrenergic and adrenergic structures in selected rat brain areas. Histochemistry 1993, 99:427-442.
4. Basso A.M., Spina M., Rivier J., Vale W., Koob G.F. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berl) 1999, 145:21-30.
5. Bernard J.F., Besson J.M. Convergence of nociceptive information on the parabrachio-amygdala neurons in the rat [in French]. C R Acad Sci III 1988, 307:841-847.
6. Bernard J.F., Huang G.F., Besson J.M. Nucleus centralis of the amygdala and the globus pallidus ventralis: electrophysiological evidence for an involvement in pain processes. J Neurophysiol 1992, 68:551-569.
7. Bissière S., Humeau Y., Lüthi A. Dopamine gates LTP induction in lateral amygdala by suppressing feedforward inhibition. Nat Neurosci 2003, 6:587-592.
8. Blair H.T., Schafe G.E., Bauer E.P., Rodrigues S.M., LeDoux J.E. Synaptic plasticity in the lateral amygdala: a cellular hypothesis of fear conditioning. Learn Mem 2001, 8:229-242.
9. Bouthenet M.L., Martres M.P., Sales N., Schwartz J.C. A detailed mapping of dopamine D-2 receptors in rat central nervous system by autoradiography with [125I]iodosulpride. Neuroscience 1987, 20:117-155.
10. Burstein R., Potrebic S. Retrograde labeling of neurons in the spinal cord that project directly to the amygdala or the orbital cortex in the rat. J Comp Neurol 1993, 335:469-485.
11. Chen S., Buckmaster P.S. Stereological analysis of forebrain regions in kainate-treated epileptic rats. Brain Res 2005, 1057:141-152.
12. Davis M. The role of the amygdala in fear-potentiated startle: implications for animal models of anxiety. Trends Pharmacol Sci 1992, 13:35-41.
13. Davis M., Whalen P.J. The amygdala: vigilance and emotion. Mol Psychiatry 2001, 6:13-34.
14. De Boer S.F., Koolhaas J.M. Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 2003, 463:145-161.
15. de Oliveira A.R., Reimer A.E., de Macedo C.E., de Carvalho M.C., Silva M.A., Brandão M.L. Conditioned fear is modulated by D2 receptor pathway connecting the ventral tegmental area and basolateral amygdala. Neurobiol Learn Mem 2011, 95:37-45.
16. Diaz J., Lévesque D., Griffon N., Lammers C.H., Martres M.P., Sokoloff P., Schwartz J.C. Opposing roles for dopamine D2 and D3 receptors on neurotensin mRNA expression in nucleus accumbens. Eur J Neurosci 1994, 6:1384-1387.
17. Diaz M.R., Chappell A.M., Christian D.T., Anderson N.J., McCool B.A. Dopamine D3-lke receptors modulate anxiety-like behavior and regulate GABAergic transmission in the rat lateral/basolateral amygdala. Neuropsychopharmacology 2011, 36:1090-1103.
18. Economidou D., Hansson A.C., Weiss F., Terasmaa A., Sommer W.H., Cippitelli A., Fedeli A., Martin-Fardon R., Massi M., Ciccocioppo R., Heilig M. Dysregulation of nociceptin/orphanin FQ activity in the amygdala is linked to excessive alcohol drinking in the rat. Biol Psychiatry 2008, 64:211-218.
19. Ehrlich I., Humeau Y., Grenier F., Ciocchi S., Herry C., Lüthi A. Amygdala inhibitory circuits and the control of fear memory. Neuron 2009, 62:757-771.
20. Engin E., Treit D. The anxiolytic-like effects of allopregnanolone vary as a function of intracerebral microinfusion site: the amygdala, medial prefrontal cortex, or hippocampus. Behav Pharmacol 2007, 18:461-470.
21. Engin E., Treit D. The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review. Prog Neuropsychopharmacol Biol Psychiatry 2008, 32:1399-1419.
22. Everitt B.J., Cardinal R.N., Parkinson J.A., Robbins T.W. Appetitive behavior: impact of amygdala-dependent mechanisms of emotional learning. Ann N Y Acad Sci 2003, 985:233-250.
23. Fallon J.H., Ciofi P. Distribution of monoamines within the amygdala. The amygdala: neurobiological aspects of emotion, memory, and mental dysfunction 1992, 9-114. Wiley-Liss, New York. J.P. Aggleton (Ed.).
24. Fernández-Guasti A., Ferreira A., Picazo O. Diazepam, but not buspirone, induces similar anxiolytic-like actions in lactating and ovariectomized Wistar rats. Pharmacol Biochem Behav 2001, 70:85-93.
25. Ferreira-Netto C., Borelli K.G., Brandão M.L. Distinct Fos expression in the brain following freezing behavior elicited by stimulation with NMDA of the ventral or dorsal inferior colliculus. Exp Neurol 2007, 204:693-704.
26. Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system: part 3. The monoamine nerve terminal. Z Zellforsch Mikrosk Anat 1965, 65:573-596.
27. Fuxe K. Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol Scand 1965, 64(Suppl 247):39-85.
28. Fuxe K., Jacobsen K.X., Höistad M., Tinner B., Jansson A., Staines W.A., Agnati L.F. The dopamine D1 receptor-rich main and paracapsular intercalated nerve cell groups of the rat amygdala: relationship to the dopamine innervation. Neuroscience 2003, 119:733-746.
29. Gauriau C., Bernard J.F. Pain pathways and parabrachial circuits in the rat. Exp Physiol 2002, 87:251-258.
30. Granon S., Passetti F., Thomas K.L., Dalley J.W., Everitt B.J., Robbins T.W. Enhanced and impaired attentional performance after infusion of D1 dopaminergic receptor agents into rat prefrontal cortex. J Neurosci 2000, 20:1208-1215.
31. Greba Q., Gifkins A., Kokkinidis L. Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Res 2001, 899:218-226.
32. Guarraci F.A., Frohardt R.J., Falls W.A., Kapp B.S. The effects of intra-amygdaloid infusions of a D2 dopamine receptor antagonist on Pavlovian fear conditioning. Behav Neurosci 2000, 114:647-651.
33. Guarraci F.A., Frohardt R.J., Kapp B.S. Amygdaloid D1 dopamine receptor involvement in Pavlovian fear conditioning. Brain Res 1999, 827:28-40.
34. Gurevich E.V., Joyce J.N. Distribution of dopamine D3 receptor expressing neurons in the human forebrain: comparison with D2 receptor expressing neurons. Neuropsychopharmacology 1999, 20:60-80.
35. Hansson A.C., Cippitelli A., Sommer W.H., Fedeli A., Björk K., Soverchia L., Terasmaa A., Massi M., Heilig M., Ciccocioppo R. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc Natl Acad Sci U S A 2006, 103:15236-15241.
36. Herry C., Ferraguti F., Singewald N., Letzkus J.J., Ehrlich I., Lüthi A. Neuronal circuits of fear extinction. Eur J Neurosci 2010, 31:599-612.
37. Huber D., Veinante P., Stoop R. Vasopressin and oxytocin excite distinct neuronal populations in the central amygdala. Science 2005, 308:245-248.
38. Inglis F.M., Moghaddam B. Dopaminergic innervation of the amygdala is highly responsive to stress. J Neurochem 1999, 72:1088-1094.
39. James M.S., Starr M.S. Effects of the rate and volume of injection on the pharmacological response elicited by intranigral microapplication of drugs in the rat. J Pharmac Meth 1978, 1:197-202.
40. Jansson A., Goldstein M., Tinner B., Zoli M., Meador-Woodruff J.H., Lew J.Y., Levey A.I., Watson S., Agnati L.F., Fuxe K. On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat. Neuroscience 1999, 89:473-489.
41. Keay K.A., Bandler R. Parallel circuits mediating distinct emotional coping reactions to different types of stress. Neurosci Biobehav Rev 2001, 25:669-678.
42. Killcross S., Robbins T.W., Everitt B.J. Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature 1997, 388:377-380.
43. Kröner S., Rosenkanz J.A., Grace A.A., Barrionuevo G. Dopamine modulates excitability of basolateral amygdala neurons in vitro. J Neurofisiol 2005, 93:1598-1610.
44. Lalonde R., Strazielle C. Relations between open-field, elevated plus-maze, and emergence tests as displayed by C57/BL6J and BALB/c mice. J Neurosci Methods 2008, 171:48-52.
45. Lamont E.W., Kokkinidis L. Infusion of the dopamine D1 receptor antagonist SCH 23390 into the amygdala blocks fear expression in a potentiated startle paradigm. Brain Res 1998, 795:128-136.
46. LeDoux J.E. Emotion circuits in the brain. Annu Rev Neurosci 2000, 23:155-184.
47. Maltais S., C té S., Drolet G., Falardeau P. Cellular colocalization of dopamine D1 mRNA and D2 receptor in rat brain using a D2 dopamine receptor specific polyclonal antibody. Prog Neuropsychopharmacol Biol Psychiatry 2000, 24:1127-1149.
48. Mansour A., Watson S.J. Dopamine receptor expression in the central nervous system. Psychopharmacology IV generation of progress 1995, 207-219. Raven Press, New York. F.E. Bloom, D.J. Kupfer (Eds.).
49. Marowsky A., Fritschy J.M., Vogt K.E. Functional mapping of GABA A receptor subtypes in the amygdala. Eur J Neurosci 2004, 20:1281-1289.
50. Marowsky A., Yanagawa Y., Obata K., Vogt K.E. A specialized subclass of interneurons mediates dopaminergic facilitation of amygdala function. Neuron 2005, 48:1025-1037.
51. Millan M.J. The neurobiology and control of anxious states. Prog Neurobiol 2003, 70:83-244.
52. Nader K., LeDoux J.E. Inhibition of the mesoamygdala dopaminergic pathway impairs the retrieval of conditioned fear associations. Behav Neurosci 1999, 113:891-901.
53. Neugebauer V., Galhardo V., Maione S., Mackey S.C. Forebrain pain mechanisms. Brain Res Rev 2009, 60:226-242.
54. Paré D., Quirk G.J., LeDoux J.E. New vistas on amygdala networks in conditioned fear. J Neurophysiol 2004, 92:1-9.
55. Paré D., Smith Y. Distribution of GABA immunoreactivity in the amygdaloid complex of the cat. Neuroscience 1993, 57:1065-1076.
56. Paxinos G., Watson C. The rat brain in stereotaxical coordinates 1986, Academic Press, San Diego.
57. Pellow S., Chopin P., File S.E., Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985, 14:149-167.
58. Perez de la Mora M.P., Cárdenas-Cachón L., Vázquez-García M., Crespo-Ramírez M., Jacobsen K., Höistad M., Agnati L., Fuxe K. Anxiolytic effects of intra-amygdaloid injection of the D1 antagonist SCH23390 in the rat. Neurosci Lett 2005, 377:101-105.
59. Perez de la Mora M.P., Gallegos-Cari A., Arizmendi-García Y., Marcellino D., Fuxe K. Role of dopamine receptor mechanisms in the amygdaloid modulation of fear and anxiety: structural and functional analysis. Prog Neurobiol 2010, 90:198-216.
60. Pérez de la Mora M., Hernández-Gómez A.M., Arizmendi-García Y., Jacobsen K.X., Lara-García D., Flores-Gracia C., Crespo-Ramírez M., Gallegos-Cari A., Nuche-Bricaire A., Fuxe K. Role of the amygdaloid cholecystokinin (CCK)/gastrin-2 receptors and terminal networks in the modulation of anxiety in the rat. Effects of CCK-4 and CCK-8S on anxiety-like behaviour and [3H]GABA release. Eur J Neurosci 2007, 26:3614-3630.
61. Pérez de la Mora M., Jacobsen K.X., Crespo-Ramírez M., Flores-Gracia C., Fuxe K. Wiring and volume transmission in rat amygdala. Implications for fear and anxiety. Neurochem Res 2008, 33:1618-1633.
62. Pérez de la Mora M., Lara-García D., Jacobsen K.X., Vázquez-García M., Crespo-Ramírez M., Flores-Gracia C., Escamilla-Marvan E., Fuxe K. Anxiolytic-like effects of the selective metabotropic glutamate receptor 5 antagonist MPEP after its intra-amygdaloid microinjection in three different non-conditioned rat models of anxiety. Eur J Neurosci 2006, 23:2749-2759.
63. Pesold C., Treit D. The central and basolateral amygdala differentially mediate the anxiolytic effects of benzodiazepines. Brain Res 1995, 671:213-221.
64. Peterson SL (1988) Drug microinjectiond in discret brain regions. Kopf Carrier No. 50. David Kopf Instruments, Tujunga, California.
65. Pezze M.A., Dalley J.W., Robbins T.W. Differential roles of dopamine D1 and D2 receptors in the nucleus accumbens in attentional performance on the five-choice serial reaction time task. Neuropsychopharmacology 2007, 32:273-283.
66. Pezze M.A., Feldon J. Mesolimbic dopaminergic pathways in fear conditioning. Prog Neurobiol 2004, 74:301-320.
67. Pinard C.R., Muller J.F., Mascagni F., McDonald A.J. Dopaminergic innervation of interneurons in the rat basolateral amygdala. Neuroscience 2008, 157:850-863.
68. Pinel J.P., Treit D. Burying as a defense response in rats. J Comp Physiol Psychol 1978, 92:708-712.
69. Prut L., Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003, 463:3-33.
70. Quirk G.J., Likhtik E., Pelletier J.G., Paré D. Stimulation of medial prefrontal cortex decreases the responsiveness of central amygdala output neurons. J Neurosci 2003, 23:8800-8807.
71. Ramos A., Berton O., Mormède P., Chaouloff F. A multiple-test study of anxiety-related behaviours in six inbred rat strains. Behav Brain Res 1997, 85:57-69.
72. Rezayof A., Hosseini S.S., Zarrindast M.R. Effects of morphine on rat behaviour in the elevated plus maze: the role of central amygdala dopamine receptors. Behav Brain Res 2009, 202:171-178.
73. Rosenkranz J.A., Grace A.A. Modulation of basolateral amygdala neuronal firing and afferent drive by dopamine receptor activation in vivo. J Neurosci 1999, 19:11027-11039.
74. Rosenkranz J.A., Grace A.A. Cellular mechanisms of infralimbic and prelimbic prefrontal cortical inhibition and dopaminergic modulation of basolateral amygdala neurons in vivo. J Neurosci 2002, 22:324-337.
75. Rosenkranz J.A., Grace A.A. Dopamine-mediated modulation of odour-evoked amygdala potentials during Pavlovian conditioning. Nature 2002, 417:282-287.
76. Sandbak T., Murison R. Behavioural responses to elevated plus-maze and defensive burying testing: effects on subsequent ethanol intake and effect of ethanol on retention of the burying response. Alcohol Alcohol 2001, 36:48-58.
77. Scibilia R.J., Lachowicz J.E., Kilts C.D. Topographic nonoverlapping distribution of D1 and D2 dopamine receptors in the amygdaloid nuclear complex of the rat brain. Synapse 1992, 11:146-154.
78. Seeman P., Van Tol H.H. Dopamine receptor pharmacology. Trends Pharmacol Sci 1994, 15:264-270.
79. Treit D., Menard J., Royan C. Anxiogenic stimuli in the elevated plus-maze. Pharmacol Biochem Behav 1993, 44:463-469.
80. Tye K.M., Prakash R., Kim S.Y., Fenno L.E., Grosenick L., Zarabi H., Thompson K.R., Gradinaru V., Ramakrishnan C., Deisseroth K. Amygdala circuitry mediating reversible and bidirectional control of anxiety. Nature 2011, 471:358-362.
81. Yang C.R., Seamans J.K. Dopamine D1 receptor actions in layers V-VI rat prefrontal cortex neurons in vitro: modulation of dendritic-somatic signal integration. J Neurosci 1996, 16:1922-1935.
82. Yin H.H., Mulcare S.P., Hilário M.R., Clouse E., Holloway T., Davis M.I., Hansson A.C., Lovinger D.M., Costa R.M. Dynamic reorganization of striatal circuits during the acquisition and consolidation of a skill. Nat Neurosci 2009, 12:333-341.
83. Yokoyama M., Suzuki E., Sato T., Maruta S., Watanabe S., Miyaoka H. Amygdalic levels of dopamine and serotonin rise upon exposure to conditioned fear stress without elevation of glutamate. Neurosci Lett 2005, 379:37-41.
84. Young A.M., Rees K.R. Dopamine release in the amygdaloid complex of the rat, studied by brain microdialysis. Neurosci Lett 1998, 249:49-52.
85. Zahrt J., Taylor J.R., Mathew R.G., Arnsten A.F. Supranormal stimulation of D1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. J Neurosci 1997, 17:8528-8535.